The major difference now is that they now have clearance to actually sell it because they don't need FDA for these markets.
Unfortunately the fact that they are developing these ancillary markets might mean that they don't expect FDA approval anytime soon. I'm sure the irony is not lost on long-time shareholders. Medizone went off in this direction 9 years ago to get around the FDA and get to market quickly. 9 years later we are waiting for FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.